News for Oramed Pharmaceuticals Inc. (ORMP)

Published at

Mar 4, 2025 4:00 PM

by gurufocus.com

positive

positive

Oramed Pharmaceuticals Issues Letter to Shareholders

PR NewswireNEW YORK, March 4, 2025 Key Highlights ”“ expected completion in YR 2025:OraTech Pharmaceuticals Inc. - A new joint venture focused on oral ins

ORMP.TA ORMP

Read more →
Published at

Jan 21, 2025 4:05 PM

by manilatimes.net

positive

positive

Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

**media[520710]**

ORMP.TA ORMP

Read more →
Published at

Jan 21, 2025 4:00 PM

by gurufocus.com

positive

positive

Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company ( SCLX, ”Scilex” or ”Company”), an innovative revenue-generating company f

ORMP.TA ORMP

Read more →
Published at

Dec 16, 2024 3:32 PM

by manilatimes.net

negative

negative

Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

**media[493692]**

ORMP.TA ORMP

Read more →
Published at

Nov 22, 2024 3:38 PM

by investing.com

positive

positive

SCLX stock touches 52-week low at $0.54 amid market challenges By Investing.com

SCLX stock touches 52-week low at $0.54 amid market challenges

ORMP

Read more →
Published at

Nov 7, 2024 10:50 PM

by investing.com

positive

positive

Scilex shares face delisting risk on Nasdaq By Investing.com

Scilex shares face delisting risk on Nasdaq

ORMP

Read more →
Published at

Oct 8, 2024 8:05 PM

by investing.com

positive

positive

Scilex reports growth in Q3 net sales for pain management products By Investing.com

Scilex reports growth in Q3 net sales for pain management products

ORMP

Read more →
Published at

Oct 8, 2024 5:50 PM

by globenewswire.com

positive

positive

Scilex Holding Company Announces Closing of a $50 Million Registered Convertible Financing

PALO ALTO, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating...

ORMP.TA ORMP

Read more →
Published at

Oct 7, 2024 11:39 PM

by investing.com

positive

positive

Scilex Holding extends payment deadline in Oramed agreement By Investing.com

Scilex Holding extends payment deadline in Oramed agreement

ORMP.TA ORMP

Read more →
Published at

Oct 7, 2024 3:52 PM

by globenewswire.com

negative

negative

Scilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial Profile

Affiliates of Murchinson, 3i LP, and existing senior debt holder, Oramed Pharmaceuticals, Inc. (“Oramed”), are expected to participate in the $50 million...

ORMP.TA ORMP

Read more →
Published at

Jul 1, 2024 6:21 PM

by investing.com

neutral

neutral

Scilex reports robust sales growth for ZTlido in June 2024 By Investing.com

Scilex reports robust sales growth for ZTlido in June 2024

ORMP

Read more →
Published at

Jun 26, 2024 8:41 PM

by investing.com

positive

positive

Oramed announces $20 million stock buyback program By Investing.com

Oramed announces $20 million stock buyback program

ORMP.TA ORMP

Read more →
Published at

Jun 26, 2024 7:43 PM

by investing.com

mixed

mixed

Oramed announces $20 million stock buyback By Investing.com

Oramed announces $20 million stock buyback

ORMP ORMP.TA

Read more →
Published at

Mar 26, 2024 9:30 AM

by marketscreener.com

positive

positive

Oramed Pharmaceuticals : 13D-Nadav Kidron -March 26, 2024 at 04:30 am EDT

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED...

ORMP.TA ORMP

Read more →
Published at

Mar 19, 2024 3:06 PM

by investing.com

positive

positive

Scilex clears debt, strengthens financial position By Investing.com

Scilex clears debt, strengthens financial position

ORMP.TA ORMP

Read more →
Published at

Jul 20, 2023 6:30 PM

by globenewswire.com

positive

positive

[Latest] Global Human Insulin Market Size/Share Worth USD 70.68 Billion by 2030 at a 8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Human Insulin Market...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE ORMP.TA ORMP NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF MRKD.BA MRK.SN MRK.PA MRK.MX MRK LLY.MX LLY.DE LLY.BA LLY LILY34.SA GSK.L GSK GS7.DE GLAXF BRM.DE BMYB34.SA BMY.MX BMY.BA BMY 6MK.DE 600867.SS 0TDD.L 0Q1G.L

Read more →
Published at

Jul 5, 2023 11:26 PM

by seekingalpha.com

positive

positive

BioLingus Limited Readies $47 Million IPO Plan (Pending:SUBL)

BioLingus is developing Liraglutide, a drug treatment for diabetes patients. Click here to see our take on SUBL.

ORMP CHMA

Read more →
Published at

May 23, 2023 3:45 AM

by prnewswire.com

mixed

mixed

Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth

/PRNewswire/ -- The "Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to...

ORMP.TA ORMP NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF 0TDD.L ZEG.DE LLY.MX LLY.DE LLY.BA LLY LILY34.SA JNJ IDP.DE GNBT DJNJ3.BA DJNJ2.BA CHGCY CHGCF BIIBD.BA BIIBCL.SN BIIB.SN BIIB.MX BIIB.BA BIIB BAX.MX BAX AZNN.MX AZNCF AZN.L AZN AMGN.MX AMGN.BA AMGN AMG.DE ABTCL.SN ABT.SN ABT 4519.T 0QK8.L 0Q1G.L 0A4J.L 002007.SZ

Read more →
Published at

Nov 18, 2022 10:11 AM

by prnewswire.com

mixed

mixed

MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea

/PRNewswire/ -- On 14th, MEDICOX (054180), listed on KOSDAQ, signed an exclusive distribution contract with an oral drug delivery platform developer, ORAMED...

ORMP 054180.KQ

Read more →
Published at

Nov 14, 2022 1:56 PM

by marketscreener.com

positive

positive

Oramed Signs Definitive Deal with Medicox to Commercialize Oral Insulin in South Korea

Medicox to Distribute Oramed's Oral Insulin in South Korea, if approvedOramed to Receive Up to $18 Million in Developmental MilestonesOramed to Receive up to 15% Royalties on Gross SalesLarge Market... | November 14, 2022

ORMP.TA ORMP 054180.KQ

Read more →